What Low Testosterone Does to Your Mood and Why TRT Changes It

The Depression Nobody Screens For

There is a man sitting in a GP surgery right now describing fatigue, loss of interest in things he used to enjoy, difficulty concentrating, disrupted sleep, irritability, and a persistent low mood that he cannot shake. He has been prescribed an SSRI. Nobody has checked his testosterone. Hemi Pharma UK supplies batch-tested Testosterone Cypionate 200mg for UK users, and the relationship between Testosterone Cypionate and depression is one of the most important and underrecognised intersections in men’s health.

This is not a fringe claim. The symptom overlap between clinical depression and male hypogonadism is so extensive that the Endocrine Society’s diagnostic criteria for testosterone deficiency explicitly list “feeling sad or blue, depressed mood, dysthymia” alongside “decreased energy, motivation, initiative, and self-confidence” as clinical indicators. A man with a total testosterone of 6 nmol/L will present identically to a man with moderate depression on every standard screening questionnaire. If nobody measures the hormone, nobody finds the cause.

Why Does Low Testosterone Cause Depression?

Understanding the connection between Testosterone Cypionate and depression requires thinking about testosterone as a neurological substance, not merely a reproductive hormone. The brain is one of the most testosterone-responsive organs in the body. Androgen receptors are densely distributed across the hippocampus, amygdala, prefrontal cortex, and hypothalamus, the very regions that regulate mood, motivation, reward processing, and emotional resilience.

The Reward System Goes Quiet

Depression is, at its neurochemical core, a failure of the brain’s reward circuitry. The dopaminergic pathways that generate motivation, anticipation, and pleasure become underactive. You stop wanting things. Activities that once generated satisfaction feel flat. Getting out of bed requires willpower that previously was not needed because the brain simply generated the momentum automatically.

Testosterone directly modulates dopaminergic activity in the mesolimbic pathway, the circuit responsible for reward, motivation, and drive. When testosterone drops, dopaminergic tone drops with it. The subjective experience is not dramatic sadness. It is a grey flatness: nothing is wrong, but nothing is right either. Food tastes the same but you do not look forward to meals. Training feels like an obligation rather than a release. Sex becomes something you could take or leave. This specific pattern, anhedonia without intense sadness, is the hallmark of testosterone-related depression and it is often misdiagnosed as treatment-resistant major depression simply because SSRIs do not fix dopamine problems in the reward circuit.

Serotonin and Neuroplasticity

Testosterone also influences serotonin receptor density, BDNF (brain-derived neurotrophic factor) production, and hippocampal neuroplasticity. BDNF is essentially fertiliser for neurons. It promotes the growth of new synaptic connections and maintains existing ones. Low BDNF is one of the most consistent findings in depressed patients across the research literature. Testosterone supports BDNF production, which means that low testosterone may contribute to the same neuroplasticity deficit that antidepressants are designed to address, just through a different pathway.

This is why some men find that Testosterone Cypionate resolves depressive symptoms that years of antidepressant medication could not fully address. The antidepressant was working on serotonin reuptake while the underlying problem was upstream: a hormonal deficit that affected dopamine, BDNF, and neuroplasticity simultaneously.

Chronic Inflammation as a Shared Mechanism

There is a third pathway connecting Testosterone Cypionate and depression that is often overlooked. Low testosterone is associated with chronic low-grade systemic inflammation: elevated IL-6, TNF-alpha, and C-reactive protein. These same inflammatory markers are elevated in a substantial subset of depressed patients. The “inflammatory theory of depression” proposes that chronic inflammation drives depressive symptoms by directly affecting neurotransmitter metabolism, disrupting the blood-brain barrier, and activating microglial cells that impair synaptic function.

Testosterone, when restored to physiological levels, reduces these inflammatory markers. A man on TRT who reports that his depression lifted may be experiencing the combined effect of restored dopaminergic tone, improved BDNF production, and reduced neuroinflammation, all triggered by a single hormonal correction. No SSRI addresses all three pathways simultaneously.

What Does the Meta-Analytic Evidence Show?

The largest and most rigorous meta-analysis on testosterone and depression was published in JAMA Psychiatry in 2019 by Walther and colleagues. It pooled data from 27 randomised controlled trials involving 1,890 men. Testosterone treatment produced a significant reduction in depressive symptoms compared with placebo (Hedges g equals 0.21, 95% CI 0.10 to 0.32). The efficacy odds ratio was 2.30 (95% CI 1.30 to 4.06), meaning men on testosterone were 2.3 times more likely to experience a clinically meaningful reduction in depression scores than men on placebo (Walther et al., JAMA Psychiatry 2019).

Meta-regression analysis revealed two critical moderators. First, higher testosterone doses produced stronger antidepressant effects. Doses above 500mg per week showed the most consistent benefit, though therapeutic replacement doses also produced significant effects. Second, the benefit was strongest when baseline symptom variability was low, meaning the treatment worked best in men with consistent, stable depressive symptoms rather than fluctuating mood disorders.

A 2025 systematic review published in PMC assessed the cumulative evidence quality as Level I to II, concluding that testosterone therapy exerts measurable antidepressant and cognitive-enhancing effects, particularly as adjunctive treatment in treatment-resistant depression and as a standalone intervention in older hypogonadal men (psychiatric and cognitive effects review, PMC 2025).

Who Responds Best to Testosterone for Depression?

Not every depressed man will improve on Testosterone Cypionate. The research consistently shows that certain profiles predict a strong antidepressant response to TRT.

Men with Confirmed Hypogonadism

The strongest evidence is in men with total testosterone below 300 ng/dL (10.4 nmol/L) and concurrent depressive symptoms. In this group, TRT addresses a genuine physiological deficiency. The depression is partly or wholly caused by the hormonal deficit, and fixing the deficit fixes the depression. A placebo-controlled trial in older hypogonadal men with subthreshold depression (dysthymia or minor depression) found a remission rate of 52.9% in the testosterone group compared to 18.8% in the placebo group after 12 weeks of testosterone gel.

Men Under 60

Subgroup analyses across multiple meta-analyses consistently show stronger antidepressant effects of TRT in men younger than 60. This likely reflects the higher prevalence of functional hypogonadism (as opposed to age-related decline) in younger men, meaning the depression-testosterone link is more direct and the response to replacement more robust. The Frontiers in Endocrinology 2023 review confirmed this pattern: significant benefits in men under 60 and hypogonadal patients, but no significant effect in eugonadal men or those over 60 (Frontiers 2023 review).

Men with Treatment-Resistant Depression

There is emerging evidence that testosterone can augment conventional antidepressant therapy in men who have partially responded to SSRIs or SNRIs but have not achieved remission. The mechanism is biologically plausible: if the residual depression is driven by the dopaminergic, neurotrophic, or inflammatory pathways that antidepressants do not fully address, adding testosterone fills the gap. This use case requires further large-scale trial data, but the existing evidence is promising enough that several UK private psychiatric services now include testosterone screening in their treatment-resistant depression workup.

Who Does NOT Respond

Men with normal testosterone levels and major depressive disorder do not show consistent improvement on TRT. The Frontiers review was explicit about this: testosterone therapy was not effective in eugonadal populations. If your testosterone is 20 nmol/L and you are depressed, the depression is not hormonally driven and adding Testosterone Cypionate will not fix it. Conventional psychiatric treatment, therapy, medication, and lifestyle intervention, remains the appropriate path.

How Quickly Does Testosterone Cypionate Improve Mood?

The timeline matters because unrealistic expectations breed premature discontinuation. Based on reported experience and clinical data, the mood effects of Testosterone Cypionate unfold in stages.

Weeks one to two: subtle. Most men notice a slight increase in energy and a marginal improvement in sleep quality. The GABAergic effects of testosterone metabolites may produce a gentle calming effect, but this is often too subtle to attribute to the injection rather than placebo.

Weeks three to four: noticeable. Energy improves more clearly. Motivation begins to return. The grey flatness of anhedonia starts to lift. Men often describe this as “caring about things again” rather than feeling euphoric. Morning erections return or increase, which is an independent marker of improved neurological and vascular function.

Weeks six to eight: substantial. By this point, testosterone has reached steady-state levels on a weekly injection protocol. Mood stabilisation becomes more consistent. The irritability of low testosterone fades. Social engagement increases. Men report feeling more like themselves rather than feeling “on something.”

Weeks eight to twelve: full effect. The combination of improved body composition (reduced visceral fat, increased lean mass), better sleep, improved sexual function, and restored neurochemical balance produces a cumulative antidepressant effect that often exceeds what any single intervention achieved previously. This is not euphoria. It is the absence of depression, which for men who have been living with it for years feels remarkable.

The Depression That Testosterone Cannot Fix

Honesty requires saying this clearly. Testosterone Cypionate and depression have a clinically meaningful relationship in men with hypogonadism. But testosterone is not an antidepressant in the conventional sense. It does not treat depression that arises from grief, trauma, relationship breakdown, existential crisis, childhood adversity, or genetic predisposition to mood disorders in the absence of hormonal deficiency.

The test is simple. Check your testosterone. If it is low and your depression arrived alongside other hypogonadal symptoms (fatigue, lost libido, lost muscle, increased body fat, cognitive fog), TRT is worth trying. If your testosterone is normal, or if your depression has been present since long before any physical symptoms, testosterone is not the answer and seeking proper psychiatric care is important.

The two approaches are not mutually exclusive. A man can be on Testosterone Cypionate for genuine hypogonadism and also benefit from therapy or antidepressant medication for coexisting psychiatric depression. Treating the hormonal component does not mean ignoring the psychological component, and vice versa.

Can Testosterone Cypionate Cause Depression?

In specific circumstances, yes.

Post-Cycle Crash

Men who cycle Testosterone Cypionate at performance doses and then stop without adequate post-cycle therapy experience a period of profound hypogonadism while endogenous production restarts. During this window, testosterone may drop to castrate levels (below 3 nmol/L). The resulting crash in mood, motivation, energy, and libido can be severe enough to resemble clinical depression. This is entirely preventable with proper PCT using Clomiphene Citrate or Tamoxifen, and it resolves as the HPT axis recovers.

Oestradiol Extremes

Both excessively high and excessively low oestradiol can produce depressive symptoms on TRT. High oestradiol (above 50 pg/mL) causes emotional lability, tearfulness, and mood instability. Crashed oestradiol (below 15 pg/mL from aggressive Anastrozole use) causes a flat, anhedonic mood with joint pain and loss of emotional range. Managing oestradiol in the 20 to 40 pg/mL range prevents both scenarios.

Unrealistic Expectations

Some men start TRT expecting euphoria and become disappointed when they feel merely normal. This is not depression caused by testosterone. It is a mismatch between expectation and pharmacological reality. Testosterone Cypionate at TRT doses restores physiological function. It does not produce a high. Men who were expecting transformation and received normalisation may interpret the result as failure, which can worsen pre-existing depressive tendencies.

What About SSRIs and Testosterone Interactions?

SSRI antidepressants can worsen several aspects of the testosterone-depression relationship. SSRIs commonly cause sexual dysfunction (decreased libido, erectile difficulty, anorgasmia), which further reduces quality of life and can deepen depression through its impact on self-esteem and relationships. SSRIs may also modestly suppress testosterone levels in some men, though the data on this is mixed.

For men on SSRIs who start TRT, the sexual side effects of the SSRI often improve as testosterone restores libido and erectile function through a separate mechanism. Some men find that once their testosterone is optimised, they can taper their SSRI with their prescriber’s guidance because the hormonal correction addressed a substantial portion of their depressive symptoms. This should never be done unilaterally. SSRI discontinuation requires medical supervision due to withdrawal effects.

Adding Proviron (Mesterolone) to a TRT protocol can further help with SSRI-induced sexual dysfunction. As a DHT derivative, Proviron provides androgenic support to sexual function without aromatising to oestradiol, and many users report improved libido and erectile quality when it is added alongside their primary testosterone.

The Bigger Picture: Why Screening Matters

The UK has one of the highest antidepressant prescription rates in Europe. NICE guidelines for depression recommend SSRIs as first-line pharmacological treatment without mandating testosterone screening. This means that a significant number of men with hypogonadal depression are being treated with medications that do not address their underlying hormonal deficit, while the actual cause goes unidentified.

If you are a man over 30 with depression that has not fully responded to conventional treatment, or if your depression arrived alongside fatigue, lost libido, lost muscle, and increased body fat, ask your GP for a testosterone blood test. It is a simple, inexpensive screen that could identify a treatable cause. If your GP declines, private blood testing services in the UK offer comprehensive hormone panels for under fifty pounds. The cost of a blood test is negligible compared to years of inadequately treated depression.

Frequently Asked Questions

Does Testosterone Cypionate work as an antidepressant?

In men with confirmed low testosterone and concurrent depressive symptoms, yes. A meta-analysis of 27 RCTs found that testosterone treatment was 2.3 times more likely to produce clinically meaningful depression reduction than placebo. The effect is strongest in hypogonadal men under 60 with stable depressive symptoms. Testosterone does not work as an antidepressant in men with normal testosterone levels.

How quickly does Testosterone Cypionate improve depression?

Subtle mood improvements typically begin within two to three weeks. Noticeable improvement in motivation and emotional engagement develops by weeks three to four. Full antidepressant effect, including improved body composition, sleep, and sexual function contributing to overall mood, usually reaches maximum by weeks eight to twelve.

Can I take Testosterone Cypionate with an antidepressant?

Yes. There is no pharmacological contraindication between Testosterone Cypionate and SSRIs or SNRIs. In fact, testosterone may improve SSRI-induced sexual dysfunction and address depressive pathways that SSRIs do not reach. Any changes to antidepressant medication should be discussed with your prescriber.

Does low testosterone cause depression or does depression cause low testosterone?

Both. The relationship is bidirectional. Low testosterone directly affects brain reward circuitry, BDNF production, and inflammatory pathways that drive depressive symptoms. Depression and its associated stress, sleep disruption, and inactivity also suppress testosterone production through HPA axis interference. Breaking the cycle often requires addressing the hormonal component alongside psychological treatment.

Why did my antidepressant not fully work?

SSRIs primarily target serotonin reuptake. If your depression is substantially driven by low testosterone, the underlying problem involves dopaminergic, neurotrophic, and inflammatory pathways that serotonin reuptake inhibition does not address. Checking testosterone levels is an appropriate step for any man with a partial response to antidepressant medication.

Can stopping Testosterone Cypionate cause depression?

Yes. Abruptly stopping testosterone after prolonged use creates a temporary hypogonadal state while the body’s natural production restarts. This can cause severe mood drops resembling clinical depression. Proper post-cycle therapy with Clomiphene Citrate or Tamoxifen accelerates recovery and reduces the severity of the crash.